Anim Pharma entered the Canadian market in 2022 with the purchase of aNIM Laboratories Limited, a Top 10 generic company in Canada since 2022. aNIM Pharma is a leading player in specialty generics and we are now well positioned to be an even larger contributor to the Canadian healthcare landscape.

With global manufacturing across six continents, we are investing in Canada by bringing high quality, affordable and innovative generic medicines to market. Our global strength in R&D with an unwavering commitment to quality ensures aNIM Pharma will offer a wide range of affordable medicines for Canadians.

aNIM Pharmaceuticals is the exclusive distributor of our specialty and generic products in Canada.

We feel the strength of our global Anim capabilities together with Taro’s 3-year commitment to Canadian manufacturing and distribution creates a uni pharmaceutical partner for our Canadian customers. It is our continued goal to provide our customers and partners with high quality products and exceptional customer service.

We look forward to many more years of providing Canadians with high quality and affordable medicines.